Agilent Technologies (NYSE:A) Reaches New 12-Month Low at $112.58

Agilent Technologies, Inc. (NYSE:AGet Rating) shares hit a new 52-week low during trading on Wednesday . The company traded as low as $112.58 and last traded at $113.13, with a volume of 7911 shares changing hands. The stock had previously closed at $113.88.

A number of analysts have commented on A shares. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $160.00 to $130.00 and set an “equal weight” rating on the stock in a research report on Monday, April 25th. Truist Financial downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday, April 19th. Evercore ISI cut their price target on Agilent Technologies from $170.00 to $155.00 and set an “outperform” rating on the stock in a report on Wednesday, February 23rd. KeyCorp decreased their price objective on Agilent Technologies from $195.00 to $155.00 and set an “overweight” rating for the company in a report on Thursday, June 2nd. Finally, SVB Leerink decreased their price objective on Agilent Technologies from $175.00 to $145.00 and set an “outperform” rating for the company in a report on Wednesday, February 23rd. Three research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $159.91.

The company has a fifty day moving average of $122.05 and a 200-day moving average of $134.44. The firm has a market cap of $33.84 billion, a P/E ratio of 27.44, a P/E/G ratio of 2.30 and a beta of 1.05. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.01 and a quick ratio of 1.49.

Agilent Technologies (NYSE:AGet Rating) last announced its quarterly earnings results on Tuesday, May 24th. The medical research company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.01. Agilent Technologies had a return on equity of 27.42% and a net margin of 19.35%. The business had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.62 billion. During the same quarter in the prior year, the company posted $0.97 earnings per share. Agilent Technologies’s revenue was up 5.4% compared to the same quarter last year. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 4.9 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 27th. Investors of record on Tuesday, July 5th will be issued a dividend of $0.21 per share. The ex-dividend date of this dividend is Friday, July 1st. This represents a $0.84 annualized dividend and a yield of 0.74%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.24%.

In other Agilent Technologies news, VP Jacob Thaysen sold 5,879 shares of the business’s stock in a transaction on Thursday, June 2nd. The stock was sold at an average price of $127.43, for a total value of $749,160.97. Following the transaction, the vice president now owns 88,737 shares of the company’s stock, valued at $11,307,755.91. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Hedge funds have recently bought and sold shares of the business. Associated Banc Corp lifted its position in shares of Agilent Technologies by 2.9% during the 4th quarter. Associated Banc Corp now owns 2,554 shares of the medical research company’s stock valued at $408,000 after buying an additional 72 shares during the last quarter. Glassman Wealth Services lifted its position in shares of Agilent Technologies by 47.4% during the 4th quarter. Glassman Wealth Services now owns 230 shares of the medical research company’s stock valued at $37,000 after buying an additional 74 shares during the last quarter. Webster Bank N. A. lifted its position in shares of Agilent Technologies by 5.3% during the 4th quarter. Webster Bank N. A. now owns 1,606 shares of the medical research company’s stock valued at $256,000 after buying an additional 81 shares during the last quarter. Franklin Street Advisors Inc. NC lifted its position in shares of Agilent Technologies by 3.9% during the 4th quarter. Franklin Street Advisors Inc. NC now owns 2,151 shares of the medical research company’s stock valued at $343,000 after buying an additional 81 shares during the last quarter. Finally, CENTRAL TRUST Co lifted its position in shares of Agilent Technologies by 4.0% during the 4th quarter. CENTRAL TRUST Co now owns 2,111 shares of the medical research company’s stock valued at $337,000 after buying an additional 82 shares during the last quarter.

Agilent Technologies Company Profile (NYSE:A)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

See Also

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.